Wanlong Pharmaceutical

Founded in May 1995, Xi'an Wanlong Pharmaceutical Joint-Stock Co., Ltd. is headquartered in the New Industrial Park of Xi'an High-tech Development Zone. With a registered capital of 75 million yuan and total assets of nearly 500 million yuan, it is a pharmaceutical production enterprise under key support from the Shaanxi Provincial Government, and a high-tech enterprise that brings together scientific research and development, production and sales, and provides comprehensive and high-quality after-sales services. It has successively received honors such as the Outstanding Gazelle Enterprise of Xi'an High-tech Zone, the National Market Quality Credit AAA-level Enterprise, and the National Enterprise with the Most Independent Innovation Capability. The company is mainly engaged in the research, development, production, and sales of large-volume injections, solid oral preparations, and chemical raw materials pharmaceuticals. Its R&D center is a provincial-level enterprise technology center. At present, a product pattern dominated by three major series—anti-infection, cardiovascular and cerebrovascular, and nutritional solutions—has been formed, with a sales network covering 31 provinces, municipalities, and autonomous regions nationwide, and sales have maintained an annual growth rate of over 40% in recent years. As the largest non-PVC soft bag infusion manufacturer in the northwestern region, in order to further expand its professional advantages in the large-volume infusion field, in 2011, Xi'an Wanlong Pharmaceutical invested more than 600 million yuan to acquire over 300 mu of land in the Yangling Development Zone for the construction of a new industrial park. In 2016, the new Yangling Industrial Park completed the construction of large-volume injection workshops (glass bottle lines and non-PVC soft bag infusion lines) and solid dosage workshops for tablets, capsules, and granules, and passed GMP certification. Meanwhile, chemical raw material pharmaceutical workshops No. 1, No. 2, and No. 3, as well as the biosynthetic raw material pharmaceutical workshop No. 4, were also successively completed and passed GMP certification. The completion of the new Yangling Industrial Park has become a milestone and a new starting point for the enterprise. Wanlong Pharmaceutical is bound to make every effort to create a new realm and achieve new brilliance.